Clover Health’s stock has surged 92.7% over the past six months, reaching a new 52-week high of $5.01 per share, partly driven by solid quarterly results. The company grew its sales at a 25.6% compounded annual growth rate over the last five years, outpacing the average healthcare company. Its adjusted operating margin rose by 25.6 percentage points over the same period, though it remains negative at 2.6% for the trailing 12 months. Free cash flow margin expanded by 14 percentage points over five years, reaching 2.5% for the trailing 12 months. The stock currently trades at 55.6 times forward price-to-earnings.
Clover Health Investments CorpSolid quarterly results and strong sales growth drove the stock surge.